MANILA, Philippines — Results of clinical trials on anti-parasitic drug ivermectin as treatment for COVID-19 may be out by the first quarter of 2022, a Department of Science and Technology (DOST) official said Monday.
“Maaari po yung clinical trial ay matapos bago matapos ang taon pero pag-aaralan pa po syempre yung mga datos at yung resulta ng naturang pag-aaral,” said DOST’s Philippine Council for Health Research and Development chief Jaime Montoya said in a televised briefing.
(The clinical trials may be finished before the end of this year but of course, we need to study the data and results of the research.)
“So nakikita po namin ay, …
Keep on reading: Clinical trial results on ivermectin’s efficacy vs COVID-19 expected by early 2022